| Summary of Net Revenue, Cost of Sales, Operating Profit, Depreciation and Amortization, Interest Expense and Assets by Segment |
The following table shows, by segment: net revenue, cost of sales, operating profit, depreciation and amortization, interest expense, and assets for the years ended November 30, 2025 and November 30, 2024:
|
|
|
|
|
|
|
|
|
|
|
For the years ended November 30, |
|
|
|
2025 |
|
|
2024 |
|
Net revenue: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
31,382,704 |
|
|
$ |
31,551,550 |
|
PrepaCyte CB |
|
|
54,104 |
|
|
|
67,884 |
|
Public cord blood banking |
|
|
129,513 |
|
|
|
366,672 |
|
Total net revenue |
|
$ |
31,566,321 |
|
|
$ |
31,986,106 |
|
Cost of sales: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
6,639,186 |
|
|
$ |
6,889,882 |
|
PrepaCyte CB |
|
|
23,280 |
|
|
|
45,082 |
|
Public cord blood banking |
|
|
714,182 |
|
|
|
1,012,788 |
|
Total cost of sales |
|
$ |
7,376,648 |
|
|
$ |
7,947,752 |
|
Operating profit: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
5,411,691 |
|
|
$ |
4,131,796 |
|
PrepaCyte CB |
|
|
14,206 |
|
|
|
(4,976 |
) |
Public cord blood banking |
|
|
(4,943,503 |
) |
|
|
(646,536 |
) |
Total operating profit |
|
$ |
482,394 |
|
|
$ |
3,480,284 |
|
Depreciation and amortization: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
734,856 |
|
|
$ |
455,324 |
|
PrepaCyte CB |
|
|
16,618 |
|
|
|
27,778 |
|
Public cord blood banking |
|
|
— |
|
|
|
420 |
|
Total depreciation and amortization |
|
$ |
751,474 |
|
|
$ |
483,522 |
|
Interest expense: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
2,066,256 |
|
|
$ |
1,864,684 |
|
PrepaCyte CB |
|
|
— |
|
|
|
— |
|
Public cord blood banking |
|
|
— |
|
|
|
— |
|
Total interest expense |
|
$ |
2,066,256 |
|
|
$ |
1,864,684 |
|
The following table shows the assets by segment as of November 30, 2025 and November 30, 2024:
|
|
|
|
|
|
|
|
|
|
|
As of |
|
|
As of |
|
|
|
November 30, 2025 |
|
|
November 30, 2024 |
|
Assets: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell
service |
|
$ |
60,788,322 |
|
|
$ |
59,259,451 |
|
PrepaCyte CB |
|
|
135,379 |
|
|
|
138,169 |
|
Public cord blood banking |
|
|
804,813 |
|
|
|
5,280,013 |
|
Total assets |
|
$ |
61,728,514 |
|
|
$ |
64,677,633 |
|
|